Trace amine-associated receptors and their ligands

R. Zucchi, G. Chiellini, Thomas (Tom) Scanlan, David Grandy

    Research output: Contribution to journalArticle

    176 Citations (Scopus)

    Abstract

    Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs). The term 'trace amines' is used when referring to p-tyramine, Β-phenylethylamine, tryptamine and octopamine, compounds that are present in mammalian tissues at very low (nanomolar) concentrations. The pharmacological effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and Β-phenylethylamine but not to classical biogenic amines. Several closely related genes were subsequently identified and designated as the trace amine-associated receptors (TAARs). Pharmacological investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, Β-phenylethylamine, tryptamine or octopamine, suggesting the existence of additional endogenous ligands. A novel endogenous thyroid hormone derivative, 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes. In vivo, micromolar concentrations of 3-iodothyronamine determine functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including reduction in body temperature and decrease in cardiac contractility. Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes. In addition, there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant association between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.

    Original languageEnglish (US)
    Pages (from-to)967-978
    Number of pages12
    JournalBritish Journal of Pharmacology
    Volume149
    Issue number8
    DOIs
    StatePublished - Dec 30 2006

    Fingerprint

    Amines
    Ligands
    Phenethylamines
    Tyramine
    Octopamine
    Biogenic Amines
    G-Protein-Coupled Receptors
    Thyroid Hormones
    Pharmacology
    Genes
    Amphetamines
    Olfactory Mucosa
    Genetic Linkage
    Body Temperature
    Mood Disorders
    Bipolar Disorder
    Histamine
    Epinephrine
    Dopamine
    Serotonin

    Keywords

    • Amphetamine
    • G-protein coupled receptors
    • Signal transduction
    • Thyroid hormone
    • Thyronamines
    • Trace amines
    • Tyramine

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Trace amine-associated receptors and their ligands. / Zucchi, R.; Chiellini, G.; Scanlan, Thomas (Tom); Grandy, David.

    In: British Journal of Pharmacology, Vol. 149, No. 8, 30.12.2006, p. 967-978.

    Research output: Contribution to journalArticle

    Zucchi, R. ; Chiellini, G. ; Scanlan, Thomas (Tom) ; Grandy, David. / Trace amine-associated receptors and their ligands. In: British Journal of Pharmacology. 2006 ; Vol. 149, No. 8. pp. 967-978.
    @article{1a35ee64d187476b885cb8a7881553b2,
    title = "Trace amine-associated receptors and their ligands",
    abstract = "Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs). The term 'trace amines' is used when referring to p-tyramine, Β-phenylethylamine, tryptamine and octopamine, compounds that are present in mammalian tissues at very low (nanomolar) concentrations. The pharmacological effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and Β-phenylethylamine but not to classical biogenic amines. Several closely related genes were subsequently identified and designated as the trace amine-associated receptors (TAARs). Pharmacological investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, Β-phenylethylamine, tryptamine or octopamine, suggesting the existence of additional endogenous ligands. A novel endogenous thyroid hormone derivative, 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes. In vivo, micromolar concentrations of 3-iodothyronamine determine functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including reduction in body temperature and decrease in cardiac contractility. Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes. In addition, there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant association between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.",
    keywords = "Amphetamine, G-protein coupled receptors, Signal transduction, Thyroid hormone, Thyronamines, Trace amines, Tyramine",
    author = "R. Zucchi and G. Chiellini and Scanlan, {Thomas (Tom)} and David Grandy",
    year = "2006",
    month = "12",
    day = "30",
    doi = "10.1038/sj.bjp.0706948",
    language = "English (US)",
    volume = "149",
    pages = "967--978",
    journal = "British Journal of Pharmacology",
    issn = "0007-1188",
    publisher = "Wiley-Blackwell",
    number = "8",

    }

    TY - JOUR

    T1 - Trace amine-associated receptors and their ligands

    AU - Zucchi, R.

    AU - Chiellini, G.

    AU - Scanlan, Thomas (Tom)

    AU - Grandy, David

    PY - 2006/12/30

    Y1 - 2006/12/30

    N2 - Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs). The term 'trace amines' is used when referring to p-tyramine, Β-phenylethylamine, tryptamine and octopamine, compounds that are present in mammalian tissues at very low (nanomolar) concentrations. The pharmacological effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and Β-phenylethylamine but not to classical biogenic amines. Several closely related genes were subsequently identified and designated as the trace amine-associated receptors (TAARs). Pharmacological investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, Β-phenylethylamine, tryptamine or octopamine, suggesting the existence of additional endogenous ligands. A novel endogenous thyroid hormone derivative, 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes. In vivo, micromolar concentrations of 3-iodothyronamine determine functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including reduction in body temperature and decrease in cardiac contractility. Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes. In addition, there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant association between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.

    AB - Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs). The term 'trace amines' is used when referring to p-tyramine, Β-phenylethylamine, tryptamine and octopamine, compounds that are present in mammalian tissues at very low (nanomolar) concentrations. The pharmacological effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and Β-phenylethylamine but not to classical biogenic amines. Several closely related genes were subsequently identified and designated as the trace amine-associated receptors (TAARs). Pharmacological investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, Β-phenylethylamine, tryptamine or octopamine, suggesting the existence of additional endogenous ligands. A novel endogenous thyroid hormone derivative, 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes. In vivo, micromolar concentrations of 3-iodothyronamine determine functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including reduction in body temperature and decrease in cardiac contractility. Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes. In addition, there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant association between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.

    KW - Amphetamine

    KW - G-protein coupled receptors

    KW - Signal transduction

    KW - Thyroid hormone

    KW - Thyronamines

    KW - Trace amines

    KW - Tyramine

    UR - http://www.scopus.com/inward/record.url?scp=33845637306&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33845637306&partnerID=8YFLogxK

    U2 - 10.1038/sj.bjp.0706948

    DO - 10.1038/sj.bjp.0706948

    M3 - Article

    VL - 149

    SP - 967

    EP - 978

    JO - British Journal of Pharmacology

    JF - British Journal of Pharmacology

    SN - 0007-1188

    IS - 8

    ER -